Tokyo Tape
Sign in
← H.U. Group Holdings

Quarterly report · Q3

4544.TEDINET S100SUU5
Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
MetricValuePeriodScopeSource row
Revenue¥177.5bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥260.9bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥201.0bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income−¥1.1bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥23.7bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income−¥2.9bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥22.0bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥23.2bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax−¥3.2bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥25.8bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)−¥3.3bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥15.7bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥18.8bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income−¥3.3bn2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥18.8bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥284.1bnat 2023-12-31Cons.Assets
Total assets¥297.9bnat 2023-03-31Cons.Assets
Total assets¥281.9bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥140.9bnat 2023-12-31Cons.Liabilities
Total liabilities¥147.9bnat 2023-03-31Cons.Liabilities
Net assets / equity¥143.2bnat 2023-12-31Cons.Net assets
Net assets / equity¥150.0bnat 2023-03-31Cons.Net assets
Net assets / equity¥153.3bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥40.4bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥44.2bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥40.4bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥44.2bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥30.5bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥46.5bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥9.4bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥32.5bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥19.2bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥9.2bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥29.6bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥24.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥4.6bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥5.8bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥10.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥-58.782023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-26.782023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥275.522022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥331.222022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥57.352022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥275.52022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥331.192022-04-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio50.4%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio50.3%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio54.4%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥4.5bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥4.5bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥4.6bn
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥110.2bn
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥110.0bn
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥214m
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentsegment profit2023-04-01 → 2023-12-31−¥8.6bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥50.7bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥46.4bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥4.3bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentsegment profit2023-04-01 → 2023-12-31¥11.0bn
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentrevenue2023-04-01 → 2023-12-31¥21.1bn
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentrevenue external2023-04-01 → 2023-12-31¥21.1bn
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥4m
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentsegment profit2023-04-01 → 2023-12-31¥938m
—segment totalrevenue2023-04-01 → 2023-12-31¥182.0bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥177.5bn
—segment totalrevenue intersegment2023-04-01 → 2023-12-31¥4.5bn
—segment totalsegment profit2023-04-01 → 2023-12-31¥3.4bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥6.2bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥6.2bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥3.3bn
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥124.9bn
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥124.7bn
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥212m
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥2.7bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥61.6bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥55.6bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥5.9bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥23.5bn
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentrevenue2022-04-01 → 2022-12-31¥20.7bn
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentrevenue external2022-04-01 → 2022-12-31¥20.6bn
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥15m
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentsegment profit2022-04-01 → 2022-12-31¥825m
—segment totalrevenue2022-04-01 → 2022-12-31¥207.1bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥201.0bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥6.2bn
—segment totalsegment profit2022-04-01 → 2022-12-31¥26.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 485
ItemContextValueUnit
Non operating incomePrior1YTDDuration1299000000JPY
Non operating incomeCurrentYTDDuration1083000000JPY
Interest expenses noePrior1YTDDuration279000000JPY
Interest expenses noeCurrentYTDDuration292000000JPY
Equity in losses of affiliates noePrior1YTDDuration1315000000JPY
Equity in losses of affiliates noeCurrentYTDDuration1844000000JPY
Other noePrior1YTDDuration179000000JPY
Other noeCurrentYTDDuration662000000JPY
Non operating expensesPrior1YTDDuration1774000000JPY
Non operating expensesCurrentYTDDuration2800000000JPY
Ordinary incomePrior1YTDDuration23208000000JPY
Ordinary incomeCurrentYTDDuration-2863000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration2622000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration433000000JPY
Gain on step acquisitions eiPrior1YTDDuration758000000JPY
Gain on step acquisitions eiCurrentYTDDuration－JPY
Gain on transfer of business eiPrior1YTDDuration－JPY
Gain on transfer of business eiCurrentYTDDuration377000000JPY
Other eiPrior1YTDDuration26000000JPY
Other eiCurrentYTDDuration69000000JPY
Extraordinary incomePrior1YTDDuration3407000000JPY
Extraordinary incomeCurrentYTDDuration880000000JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration60000000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration863000000JPY
Loss on valuation of investment securities elPrior1YTDDuration88000000JPY
Loss on valuation of investment securities elCurrentYTDDuration295000000JPY
Loss on valuation of other investments elPrior1YTDDuration217000000JPY
Loss on valuation of other investments elCurrentYTDDuration－JPY
Other elPrior1YTDDuration430000000JPY
Other elCurrentYTDDuration94000000JPY
Extraordinary lossPrior1YTDDuration796000000JPY
Extraordinary lossCurrentYTDDuration1253000000JPY
Income before income taxesPrior1YTDDuration25819000000JPY
Income before income taxesCurrentYTDDuration-3236000000JPY
Income taxes currentPrior1YTDDuration3934000000JPY
Income taxes currentCurrentYTDDuration2149000000JPY
Income taxes deferredPrior1YTDDuration3039000000JPY
Income taxes deferredCurrentYTDDuration-2040000000JPY
Income taxesPrior1YTDDuration6974000000JPY
Income taxesCurrentYTDDuration108000000JPY
Profit lossPrior1YTDDuration18845000000JPY
Profit lossCurrentYTDDuration-3345000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration18845000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration-3345000000JPY
Profit lossPrior1YTDDuration18845000000JPY
Profit lossCurrentYTDDuration-3345000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-1301000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration480000000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration2549000000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration3210000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass